Science 37 Holdings, Inc. (SNCE) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Healthcare Information Services 산업에서 운영. 본사 소재지는 Research Triangle Park, NC, 미국. 현재 CEO는 David Coman.
SNCE 을(를) 보유 IPO 날짜 2020-11-23, 460 명의 정규직 직원, 에 상장 NASDAQ Global Market, 시가총액 $34.66M.
Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.
